Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
27
users have liked this narrative
8
users have commented on this narrative
76
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
97
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
CACI International
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Budget Crunch And Automation Will Threaten US Defense Contracts
Key Takeaways Increased defense budget scrutiny and automation trends threaten CACI's core revenue streams and legacy service margins. Reliance on U.S. government contracts and rising industry competition heighten risk of revenue volatility and margin compression.
View narrative
US$365.70
FV
35.3% overvalued
intrinsic discount
5.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Lincoln Electric Holdings
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Legacy Welding Reliance Will Strain Future Margins Despite Modest Automation
Key Takeaways Heavy reliance on traditional welding and slow expansion into innovative technologies exposes Lincoln Electric to cyclical downturns and long-term structural risks. Regulatory pressures, industry automation shifts, and supply chain disruptions threaten margins and earnings unless adaptation accelerates across products and operations.
View narrative
US$189.00
FV
26.7% overvalued
intrinsic discount
3.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Eastman Chemical
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Asian Dumping And Tariffs Will Crimp Chemical Margins
Key Takeaways Exposure to trade restrictions, anti-plastic mandates, and aggressive Asian competition threatens demand, pricing power, and global market share across key business segments. Substantial capital and regulatory costs, environmental liabilities, and declining margins may limit cash flow, earnings growth, and overall financial resilience.
View narrative
US$60.00
FV
2.7% overvalued
intrinsic discount
-1.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
C.H. Robinson Worldwide
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
Onshoring And Autonomous Trends Will Erode Freight Margins
Key Takeaways Shifting industry trends and technology threaten the company's intermediary role, undermining pricing power and compressing margins. Regulatory demands and digital disintermediation increase costs while eroding growth prospects and the ability to maintain a competitive operational edge.
View narrative
US$86.46
FV
35.1% overvalued
intrinsic discount
0.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Jones Lang LaSalle
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Remote Work And ESG Pressures Will Shrink Office Fee Revenues
Key Takeaways Structural shifts toward remote work, regulatory pressures, and digital disruption threaten JLL's leasing, property management, and transactional revenue streams and margins. Adverse interest rates, tighter credit, and climate-related risks are expected to weaken transaction volumes, increase costs, and reduce commercial property values.
View narrative
US$238.00
FV
16.9% overvalued
intrinsic discount
5.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Bio-Techne
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
US Funding Uncertainty Will Squeeze Life Sciences Yet Spark Resilience
Key Takeaways Uncertain government funding and strained healthcare budgets may limit growth prospects and dampen demand from key academic and biotech customers. Competitive pressures, pricing challenges, and over-reliance on emerging markets could threaten margin expansion and revenue stability.
View narrative
US$53.00
FV
4.9% undervalued
intrinsic discount
5.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
2 days ago
author updated this narrative
New Oriental Education & Technology Group
AN
AnalystLowTarget
Consensus Narrative from 23 Analysts
China's Shrinking Student Base And Digital Shift Will Squeeze Margins
Key Takeaways Structural contraction in the addressable market and regulatory challenges threaten revenue growth, margin stability, and core business enrollment. Rising competition from EdTech, shifting consumer preferences to digital learning, and higher fixed costs may erode market share and increase earnings volatility.
View narrative
US$38.65
FV
17.9% overvalued
intrinsic discount
6.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Franklin Resources
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Legacy Fees And Rising Tech Rivals Will Weaken Prospects
Key Takeaways Persistent outflows from active funds and rising competition from fintech disruptors threaten Franklin's fee income, asset base, and long-term earnings power. High costs, limited scale, and unproven digital investments constrain margin expansion, leaving Franklin exposed to ongoing revenue and profitability challenges.
View narrative
US$19.00
FV
31.5% overvalued
intrinsic discount
-0.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Medpace Holdings
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Accelerating Costs And Funding Risk Will Undermine Biotech Stability
Key Takeaways Reliance on unsustainable short-term growth drivers and accelerated backlog conversion increases risks of revenue slowdown, margin compression, and reduced earnings visibility in coming years. High client concentration and sector funding risks, combined with escalating regulatory and operational pressures, threaten revenue stability, pricing power, and long-term market positioning.
View narrative
US$305.00
FV
42.4% overvalued
intrinsic discount
6.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies